Floatz logo

PREDNISOLONE SODIUM PHOSPHATE

Clinically Isolated Syndrome

Lakefront Biotherapeutics NVSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Clinically Isolated Syndrome cohort.

Asset / SponsorPhaseRating
Interferon ?1 (human fibroblast protein moiety)
Merck KGaA, Darmstadt, Germany
Phase 4BBB
Ocrevus
Hoffmann-La Roche
Phase 4BBB
Arestin
University of Calgary
Phase 3B
Tovaxin
Opexa Therapeutics, Inc.
Phase 2CCC

Same molecule, other indications

PREDNISOLONE SODIUM PHOSPHATE is also rated in:

relapsing-remitting multiple sclerosisDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →